Dg Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Dg Capital Management, LLC

  • $172 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$17.78 - $33.08 $7.15 Million - $13.3 Million
-402,200 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$10.93 - $23.55 $2.61 Million - $5.63 Million
-238,954 Reduced 37.27%
402,200 $8.9 Million
Q2 2021

Aug 12, 2021
BUY
$10.0 - $14.52 $500,000 - $726,000
50,000 Added 8.46%
641,154 $8.31 Million
Q1 2021

May 13, 2021
BUY
$12.3 - $18.73 $7.27 Million - $11.1 Million
591,154 New
591,154 $7.68 Million

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Dg Capital Management, LLC Portfolio

Follow Dg Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dg Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email